One of the most common causes of maternal death worldwide is postpartum
haemorrhage (PPH). It is estimated that severe postpartum hemorrhage occurs in
about 11% of women having a living newborn. It is believed that the incidence is
much higher in developing countries, where most of the women are unable to
have access to a birth assisted by trained personnel and there is not an active
management of the third stage of labour.
Key messages
Postpartum haemorrhage is one of the most common causes of maternal
death in low and middle-income countries.
There is insufficient evidence to show that the addition of misoprostol is
superior to the combination of oxytocin and ergometrine for the treatment of
primary PPH.
Misoprostol is potentially a very useful intervention for treatment of PPH but
more research is needed to assess the effect on severe maternal morbidities
outcomes, as well as its side-effect profile.